ANACMS · 古今回响
← 返回展馆

古今回响 · 玖

Echoes Across Time

ANCIENT RECORDS, MODERN VERIFICATION

古有明训,今有实证

Ancient teachings, modern proof

中医药的历史记载中,有一些具体的观察或做法,后来被现代科学方法验证了效果、或阐明了机制。以下六组案例逐一呈现古籍原文(或民间用药记载)与对应的现代研究关键节点,均标注可查证的文献出处。其中两组案例(针刺镇痛机制、人痘接种术)的现代验证范围有明确限定,请留意各案例下方的"说明"框。本厅所述均为已发生的科学史事实,不构成对任何具体病症的诊疗建议。

Among the historical records of Chinese medicine, certain specific observations or practices were later validated or mechanistically clarified through modern scientific methods. The six case studies below each present a classical text (or a record of folk medicinal use) alongside the corresponding modern research milestone, with verifiable sources cited throughout. Two cases (the mechanism of acupuncture analgesia, and the practice of smallpox inoculation) have clearly bounded claims — please note the highlighted boxes beneath each. Everything presented here concerns established facts of science history, and does not constitute clinical advice for any specific condition.

本厅案例的选取标准为:有明确、可交叉核验的文献出处;现代验证部分为已被学术界确认、且无重大署名权或优先权争议的具体发现。展示范围严格限定在已证实的具体结论上,不作扩大化的疗效宣称,亦不涉及对现实病症的诊断或用药建议。

Cases in this hall are selected according to the following criteria: sources that are clear and can be cross-verified; and modern findings that are academically established without major disputes over authorship or priority. The scope presented is strictly limited to confirmed conclusions, without overstated claims of efficacy, and does not offer diagnostic or medicinal advice for real-world conditions.

先玩一轮"古今连线",试试能不能把六段古籍记载和六个现代发现配对成功?

Try "Match the Eras" first — can you pair all six classical records with their modern discoveries?

开始连线游戏 →Start the Game →
药物发现类 · Drug Discovery 诊疗技术类 · Technique 公共卫生类 · Public Health

药物发现类

Drug Discovery

FOUR CASES
1

青蒿素:从"绞汁服用"到诺贝尔奖

Artemisinin: From a Crushed-Juice Remedy to the Nobel Prize

Artemisinin 跨越约1600年 · 东晋—1971年 Roughly 1,600 years · Eastern Jin dynasty to 1971

古籍记载

Classical Record

"青蒿一握,水二升渍,绞取汁,尽服之。"——东晋·葛洪《肘后备急方》
"Take a handful of qinghao (sweet wormwood), soak in two sheng of water, wring out the juice, and drink it entirely." — Ge Hong, Handbook of Prescriptions for Emergencies, Eastern Jin dynasty

这是现存中医文献中关于青蒿治疟的早期记载之一,采用的是常温绞汁,而非传统的水煎法。

One of the earliest surviving records of qinghao used against malaria in Chinese medical literature, notably using cold-pressed juice rather than the conventional decoction method.

现代验证

Modern Verification

屠呦呦团队自1969年加入"523任务",历经190余次失败后重新审视古方原文,注意到传统水煎工艺的高温可能破坏有效成分,遂改用低温乙醚提取法,1971年成功获得抗疟效果显著的青蒿素结晶,2015年获诺贝尔生理学或医学奖。

From 1969, Tu Youyou's team, working on the national "Project 523," reviewed the classical text after more than 190 failed attempts, noting that the high heat of traditional decoction might destroy the active compound. Switching to low-temperature ether extraction, the team successfully isolated artemisinin in 1971; the discovery was awarded the 2015 Nobel Prize in Physiology or Medicine.

出处:葛洪《肘后备急方》;新华网「屠呦呦为何能获诺奖?」;中国中医科学院官网屠呦呦专题;诺贝尔奖官网 2015年生理学或医学奖公告。 Sources: Ge Hong, Handbook of Prescriptions for Emergencies; Xinhua News Agency feature on Tu Youyou's Nobel Prize; China Academy of Chinese Medical Sciences tribute page; Nobel Prize official announcement, 2015 Physiology or Medicine.

想亲自走一遍屠呦呦团队当年的推理过程吗?五个关键节点,站在1969年研究者的角度做出判断。

Want to retrace Tu Youyou's team's reasoning yourself? Five key junctures — judge each one as a researcher would have in 1969.

挑战推理闯关 →Take the Reasoning Quest →
2

麻黄碱:从"发表出汗"到现代药理学

Ephedrine: From "Inducing Sweat" to Modern Pharmacology

Ephedrine 跨越约2000年 · 汉代—1923年 Roughly 2,000 years · Han dynasty to 1923

古籍记载

Classical Record

麻黄"主中风伤寒头痛,温疟,发表出汗,去邪热气,止咳逆上气,除寒热,破癥坚积聚。"——《神农本草经》
Ephedra "treats wind-stroke, cold damage and headache, warm malaria; induces sweating to release the exterior; dispels pathogenic heat; stops cough and counterflow qi..." — Divine Farmer's Materia Medica

《伤寒论》中的麻黄汤是治疗表证兼喘咳的经典方剂,沿用至今。

The Ephedra Decoction in the Treatise on Cold Damage remains a classical formula for exterior syndromes with cough and wheezing, still used today.

现代验证

Modern Verification

留美药理学家陈克恢1923年返聘北京协和医学院药理系,与同事施密特合作,通过动物实验证明麻黄碱具有和肾上腺素类似的收缩血管、松弛支气管平滑肌作用,被视为中药现代药理学研究的开创性工作之一。

Pharmacologist Ko-Kuei Chen, upon returning to the Pharmacology Department at Peking Union Medical College in 1923, worked with colleague Carl Schmidt to demonstrate through animal experiments that ephedrine has vasoconstrictive and bronchodilatory effects similar to adrenaline — considered one of the pioneering works of modern pharmacological research on Chinese herbal medicine.

出处:《神农本草经》;《伤寒论》;陈克恢、施密特相关药理学研究记录;维基百科「陳克恢」条目;相关医学史综述文章。 Sources: Divine Farmer's Materia Medica; Treatise on Cold Damage; pharmacological research records of Ko-Kuei Chen and Carl Schmidt; Wikipedia entry "Ko-Kuei Chen"; related medical history reviews.
3

黄连素(小檗碱):从治痢古药到降脂新机制

Berberine: From an Ancient Anti-Dysentery Herb to a New Lipid-Lowering Mechanism

Berberine 跨越约2000年 · 汉代—2004年 Roughly 2,000 years · Han dynasty to 2004

古籍记载

Classical Record

黄连"主热气,目痛,眦伤,泣出,明目,肠澼,腹痛,下痢……久服令人不忘。"——《神农本草经》
Coptis "treats heat qi, eye pain... intestinal disorders, abdominal pain, dysentery... long-term use improves memory." — Divine Farmer's Materia Medica

历代中医主要用黄连清热燥湿、治疗肠道感染腹泻,这一用法沿用至今。

Throughout history, Coptis has mainly been used to clear heat and dampness and treat intestinal infections with diarrhea, a use that continues today.

现代验证

Modern Verification

中国医学科学院药物研究所团队(论文第一作者孔炜等)于2004年在《自然·医学》(Nature Medicine)发表研究,证实小檗碱是一种与他汀类药物机制不同的全新降脂药物。

A research team from the Institute of Materia Medica, Chinese Academy of Medical Sciences (first author Wei Kong et al.) published findings in Nature Medicine in 2004, demonstrating that berberine is a novel cholesterol-lowering agent working through a mechanism distinct from statins.

出处:《神农本草经》;Kong W, Wei J, et al. "Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins." Nature Medicine, 2004;中国医学科学院药物研究所官网相关报道。 Sources: Divine Farmer's Materia Medica; Kong W, Wei J, et al. "Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins." Nature Medicine, 2004; Institute of Materia Medica, Chinese Academy of Medical Sciences.
4

石杉碱甲:从千层塔的副作用到阿尔茨海默病新药

Huperzine A: From a Folk Herb's Side Effect to an Alzheimer's Drug

Huperzine A 1982年—1996年 1982 to 1996

民间用药记载

Folk Medicinal Record

千层塔(学名蛇足石杉)为民间常用草药,用于治疗肺炎、跌打损伤等症,服用者常出现腹痛、流涎、肌肉抽搐等"外周胆碱能样副作用"。
Qian Ceng Ta (Huperzia serrata) is a folk herb traditionally used for pneumonia and traumatic injury; users commonly experienced abdominal pain, salivation, and muscle twitching — "peripheral cholinergic-like side effects."

此案例源头并非经典本草医籍的功效记载,而是民间用药实践中反复出现的副作用现象。

Unlike the other cases, this one does not originate from a classical materia medica text, but from a recurring side-effect pattern observed in folk medicinal practice.

现代验证

Modern Verification

中科院上海药物研究所唐希灿院士团队注意到这些副作用背后可能隐藏活性成分,1982年由浙江医学科学院药物研究所与上海药物研究所植物化学室合作分离出石杉碱甲(研究员刘嘉森确证为新生物碱),1986年首次于《中国药理学报》报道,1996年正式获得国家新药证书上市。

Academician Tang Xican's team at the Shanghai Institute of Materia Medica, CAS, recognized these side effects might indicate an active compound. In 1982, a joint effort with the Zhejiang Institute of Materia Medica isolated huperzine A (confirmed as a new alkaloid by researcher Liu Jiasen); it was first reported in the Acta Pharmacologica Sinica in 1986, and received official new-drug approval in China in 1996.

出处:《中国药理学报》1986年相关报道;ChemicalBook「千层塔提取物石杉碱甲的研发经历简介」;国家新药审批相关公开记录。 Sources: Acta Pharmacologica Sinica, 1986 report; ChemicalBook overview of huperzine A development history; publicly available Chinese national new-drug approval records.

诊疗技术类

Technique

ONE CASE
5

针刺镇痛机制:纳洛酮阻断实验

The Mechanism of Acupuncture Analgesia: The Naloxone-Blocking Experiment

Acupuncture Analgesia Mechanism 1970年代起 Since the 1970s

传统认识

Traditional Understanding

针灸理论体系中素有"通经络、调气血"以止痛之说,散见于《黄帝内经》等针灸典籍。
The acupuncture tradition has long held that "unblocking the meridians and regulating qi and blood" can relieve pain, as recorded in texts such as the Yellow Emperor's Inner Canon.

现代验证

Modern Verification

北京大学韩济生院士自20世纪70年代起用现代神经科学方法研究针刺镇痛的客观机制,通过关键实验证明针刺时体内会释放内源性镇痛物质,并用阿片受体阻断剂纳洛酮做对照实验——注射纳洛酮后针刺镇痛效果被显著阻断,从而证明这一现象存在客观的神经化学基础。

Since the 1970s, Academician Han Jisheng of Peking University used modern neuroscience methods to study the objective mechanism of acupuncture analgesia. Key experiments showed that acupuncture triggers the release of endogenous pain-relieving substances; using the opioid receptor blocker naloxone as a control, the analgesic effect of acupuncture was significantly blocked after naloxone injection — demonstrating an objective neurochemical basis for the phenomenon.

说明:本案例表述严格限定在"这一具体实验证明了针刺镇痛存在内源性镇痛物质释放机制"这一点上,不延伸表述为针灸对所有病症普遍科学有效。国际学界关于针灸整体疗效评估(穴位特异性作用与仪式性安慰效应的比例)仍存在持续讨论,本厅不介入这一更大范围的争论。 Note:This case is strictly limited to the specific finding that acupuncture analgesia involves the release of endogenous pain-relieving substances. It should not be extended to claim that acupuncture is universally effective for all conditions. Ongoing academic debate about the overall efficacy of acupuncture — the relative contribution of point-specific effects versus ritual-associated placebo effects — is not addressed here.
出处:韩济生相关学术演讲与研究记录(北京大学基础医学院、中国科学院院士材料);《针刺研究》期刊相关论文;公开报道「专访韩济生:让世界认识针灸的科学和价值」。 Sources: academic talks and research records of Han Jisheng (Peking University School of Basic Medical Sciences; CAS academician materials); related papers in the Journal of Acupuncture Research; public interview features on Han Jisheng's work.

公共卫生类

Public Health

ONE CASE
6

人痘接种术:中国经验对现代免疫学的启发

Variolation: China's Contribution to the Origins of Modern Immunology

Variolation 宋代—1796年 Song dynasty to 1796

历史记载

Historical Record

人痘接种技术预防天花在中国有着悠久的实践传统,至少可追溯至宋代。这一技术经由俄国传至土耳其,1721年英国驻土耳其公使夫人蒙塔古夫人在君士坦丁堡学会接种法后带回英国推广。

The practice of variolation to prevent smallpox has a long tradition in China, traceable to at least the Song dynasty. The technique spread via Russia to Turkey, and in 1721, Lady Mary Wortley Montagu, wife of the British ambassador to the Ottoman Empire, learned the method in Constantinople and brought it back to Britain.

后续发展

Subsequent Development

这项技术后来启发了英国医生詹纳于1796年发明更安全的牛痘接种法,直接开启了现代免疫学和疫苗学的先河。

This practice later inspired English physician Edward Jenner to develop the safer cowpox vaccination method in 1796, directly opening the way for modern immunology and vaccine science.

说明:本案例主线严格限定在有多方史料交叉印证、国际科学史学界公认的部分(人痘技术经土耳其传入英国、启发牛痘接种法)。个别文献中提到的具体人物轶事(如清代文献追记的宋代宫廷种痘故事),因成书年代距事件本身跨度较大,属于追记性记载,不作为确凿史实呈现。 Note:This case is strictly limited to the internationally recognized, cross-verified historical account (variolation spreading via Turkey to Britain, and inspiring cowpox vaccination). Specific anecdotes found in individual later texts (such as Qing-dynasty records retrospectively describing a Song-dynasty court inoculation) are noted as retrospective accounts rather than presented as established fact, given the centuries-long gap between the events and their recording.
出处:科普时报「奇哉痘可种先天资后天」;中华读书报「玛丽·蒙塔古对防治天花的贡献」;北京中医药大学博物馆科普资料「中国古代怎样防疫」;相关医学史综述。 Sources: Science and Technology Daily feature on the history of variolation; Guangming Daily feature on Lady Mary Wortley Montagu's contribution to smallpox prevention; Beijing University of Chinese Medicine Museum public science materials; related medical history reviews.

本厅内容持续核实与更新中,如发现史实疑问或文献出处问题,欢迎通过首页联系方式告知我们。 Content in this hall is continuously verified and updated. If you notice any factual issues or citation errors, please let us know via the contact information on the homepage.